Gonadorelin Injectable (Drug Depot) – Sterility Concern (2022)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Pharmacy
Brand
Drug Depot, Inc., dba APS Pharmacy
Lot Codes / Batch Numbers
Lots: 745708 BUD: 6/21/2022, 753364 BUD: 7/27/2022, 752508 BUD: 7/24/2022, 750313 BUD: 7/16/2022, 753020 BUD: 7/26/2022, 747712 BUD: 7/4/2022, 747974 BUD: 7/5/2022, 754802 BUD: 8/3/2022, 751158 BUD: 7/19/2022, 756837 BUD: 8/16/2022, 748939 BUD: 7/10/2022, 750842 BUD: 7/18/2022, 755742 BUD: 8/8/2022, 758691 BUD: 8/28/2022, 758432 BUD: 8/27/2022, 758975 BUD: 8/29/2022, 756643 BUD: 8/15/2022
Products Sold
Lots: 745708 BUD: 6/21/2022; 753364 BUD: 7/27/2022; 752508 BUD: 7/24/2022; 750313 BUD: 7/16/2022; 753020 BUD: 7/26/2022; 747712 BUD: 7/4/2022; 747974 BUD: 7/5/2022; 754802 BUD: 8/3/2022; 751158 BUD: 7/19/2022; 756837 BUD: 8/16/2022; 748939 BUD: 7/10/2022; 750842 BUD: 7/18/2022; 755742 BUD: 8/8/2022; 758691 BUD: 8/28/2022; 758432 BUD: 8/27/2022; 758975 BUD: 8/29/2022; 756643 BUD: 8/15/2022
Drug Depot, Inc., dba APS Pharmacy is recalling GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Ph due to Lack of sterility assurance.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of sterility assurance.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026